Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
CASE REPORTS
Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination
Daisuke MatanoToshikazu MoriwakiYoshitaka TangeYusuke NiisatoMasamichi YamauraMasaomi NagaseDaisuke SuganumaKaoruko Takagi TaketaKentaro IwaiChiaki EnamiYoshiyuki YamamotoIchinosuke Hyodo
Author information
JOURNALS OPEN ACCESS

2017 Volume 56 Issue 8 Pages 921-923

Details
Abstract

Nanoparticle albumin-bound (nab)-paclitaxel has shown promising activity in advanced gastric cancer treatment. We herein report a case of advanced gastric cancer involving long-term management with a single administration of nab-paclitaxel. A 71-year-old man diagnosed with advanced gastric cancer with malignant ascites was treated with nab-paclitaxel as a second-line chemotherapy. He refused treatment continuation because of various severe toxicities in the first treatment cycle; he was therefore followed-up without any further treatments. Despite this, no disease progression was observed over 9 months. After progression, he received dose-dense paclitaxel, but he did not respond to this treatment and eventually died.

Information related to the author
© 2017 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top